NVision Imaging
NVision has developed a quantum-based platform which polarizes natural metabolites, enabling these safe molecules to be used as an agent for imaging tumor metabolism via standard MRI. This safe imaging technology will provide clinicians worldwide unprecedented early insights into treatment efficacy, allowing non-responders to be moved onto another line of therapy more quickly. The company is based in Ulm, Germany, and active throughout the US and Europe.
Revolutionizing medical imaging
Get to know NVision Imaging
Headquartered in: Ulm, Germany
Founded in: 2009
Sector: MedTech, Diagnostics
Investor: Private Investor Network, Industrial Tech Fund